Bilwadi agada followed by Nalpamaradi oil tropical application in fungal infection

Effect of topical application of bilwadi agada followed by nalpamaradi taila in dadru wsr to tinea corporis: an open labelled clinical trial - nil

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/065927

Enrollment

Registered

2024-04-18

Start date

Unknown

Completion date

Unknown

Last updated

2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere Health Condition 2: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient diagnosed with Tinea corporis Patients aged between 18 to 60 years Irrespective of sex Positive mycological findings of less than 30 Percentage of the body surface involvement will be recruited for the study

Exclusion criteria

Exclusion criteria: Patients undergoing antifungal treatment Generalized skin conditions such as herpes zoster urticaria pemphigus and psoriasis Patient with Diabetes mellitus and uncontrolled hypertension Systemic diseases RA Liver and renal dysfunction Patient with the treatment of phototherapy and corticosteroids Hypersensitive patients

Design outcomes

Primary

Measure	Time frame
primary outcome- decrease in fungal load from 0th day to 21st dayTimepoint: 0th 11th and 21st day	—

Secondary

Measure	Time frame
KANDU Itching RAGA Erythema PIDAKA Eruption ROOKSHATA Dryness UTSANNA MANDALA Elevation of lesion Timepoint: oth 11th & 21st day	—

Countries

India

Contacts

Public ContactDr Rudramma R Hiremath

KAHERs Shri B M Kankanawadi Ayurveda Mahavidyalaya Shahapur Belagavi

drrrhiremath99@gmail.com9480539098

Outcome results